v3.25.2
Condensed Consolidated Statements of Stockholders' Deficit (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive (loss) Income [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ (136,206) $ 12 $ 1,350,981 $ (161) $ (1,487,038)
Beginning balance,Shares at Dec. 31, 2023   7,661,000      
Vesting of restricted stock (in shares)   113,000      
Shares issued under the employee stock purchase plan, (in shares)   77,000      
Shares issued under the employee stock purchase plan 772   772    
Issuance of common stock for financial advisory fee (in shares)   458,000      
Issuance of common stock for financial advisory fee 6,928 $ 1 6,927    
Stock-based compensation 10,380   10,380    
Unrealized loss on investments (49)     (49)  
Foreign currency cumulative translation adjustment (395)     (395)  
Net Income (Loss) (13,570)       (13,570)
Ending balance at Jun. 30, 2024 (132,140) $ 13 1,369,060 (605) (1,500,608)
Ending balance,Shares at Jun. 30, 2024   8,309,000      
Beginning balance at Mar. 31, 2024 (168,955) $ 12 1,355,951 (518) (1,524,400)
Beginning balance,Shares at Mar. 31, 2024   7,764,000      
Vesting of restricted stock (in shares)   10,000      
Shares issued under the employee stock purchase plan, (in shares)   77,000      
Shares issued under the employee stock purchase plan 772   772    
Issuance of common stock for financial advisory fee (in shares)   458,000      
Issuance of common stock for financial advisory fee 6,928 $ 1 6,927    
Stock-based compensation 5,410   5,410    
Unrealized loss on investments (10)     (10)  
Foreign currency cumulative translation adjustment (77)     (77)  
Net Income (Loss) 23,792       23,792
Ending balance at Jun. 30, 2024 (132,140) $ 13 1,369,060 (605) (1,500,608)
Ending balance,Shares at Jun. 30, 2024   8,309,000      
Beginning balance at Dec. 31, 2024 (186,017) $ 13 1,377,786 (356) (1,563,460)
Beginning balance,Shares at Dec. 31, 2024   8,413,000      
Vesting of restricted stock (in shares)   172,000      
Shares issued under the employee stock purchase plan, (in shares)   62,000      
Shares issued under the employee stock purchase plan 356   356    
Stock-based compensation 7,344   7,344    
Unrealized loss on investments (46)     (46)  
Foreign currency cumulative translation adjustment 151     151  
Net Income (Loss) (60,714)       (60,714)
Ending balance at Jun. 30, 2025 (238,926) $ 13 1,385,486 (251) (1,624,174)
Ending balance,Shares at Jun. 30, 2025   8,647,000      
Beginning balance at Mar. 31, 2025 (205,884) $ 13 1,381,346 (321) (1,586,922)
Beginning balance,Shares at Mar. 31, 2025   8,568,000      
Vesting of restricted stock (in shares)   17,000      
Shares issued under the employee stock purchase plan, (in shares)   62,000      
Shares issued under the employee stock purchase plan 356   356    
Stock-based compensation 3,784   3,784    
Unrealized loss on investments (20)     (20)  
Foreign currency cumulative translation adjustment 90     90  
Net Income (Loss) (37,252)       (37,252)
Ending balance at Jun. 30, 2025 $ (238,926) $ 13 $ 1,385,486 $ (251) $ (1,624,174)
Ending balance,Shares at Jun. 30, 2025   8,647,000